Role of Nerve Block in Management of Multiple Rib Fractures

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-70
SponsorAssiut University

About this trial

* Epidemiology \& Impact Thoracic trauma is a common and serious injury worldwide-especially in developing countries-and carries high rates of morbidity and mortality. Complications arise primarily from hypoventilation, which leads to atelectasis, pneumonia, and respiratory failure. * Key to Reducing Complications: Pain Control Effective analgesia is the cornerstone of preventing respiratory complications. Inadequate pain relief causes patients to splint and hypoventilate, setting the stage for pulmonary collapse and infection. * Conservative Management * Analgesics: Systemic pharmacological pain relief remains the mainstay. * Supportive Measures: Rest, application of ice, and encouragement of deep breathing exercises. * Incentive Spirometry: Promoted in all patients to maintain lung expansion and ward off atelectasis. * Regional Anesthesia Techniques

To further improve comfort and respiratory mechanics, ultrasound-guided nerve blocks are employed according to fracture location:

* Serratus Anterior Plane Block for anterolateral rib fractures * Thoracic Paravertebral Block for posterior rib fractures * Surgical Intervention Reserved for complex cases-such as flail chest or fractures with risk of organ injury-where stabilization or repair may be necessary. * Identified Gap Despite these options, thoracic surgeons currently lack a standardized, procedure-specific pain management protocol beyond systemic analgesics, highlighting a need for consensus guidelines that integrate pharmacological and regional techniques.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All trauma adult patient (18-70 years) with multiple fracture ribs

Disqualifiers

Patient with multiple fracture rib with anterior flail segment

Significant head trauma

Trial design

Design model

Parallel

Treatments tested in this trial

  • Nerve block with Lidocain

    Procedure/Surgery

    Injection of Lidocaine (7mg/kg) with Epinephrine 1:100000 under Ultrasonographical guidance

  • pharmacological analgesics

    Drug

    Oral Paracetamol (500mg/6hr), IV Ketolac (15mg/6hr) and IV perfelgan (1gm/6hr)

Treatment groups

74 Participants
are divided into 2 treatment groups
Group A: nerve blockActive comparator 1 intervention
Group B: pharmacological analgesicsActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Improvement in patients pain score (neumerical score)

Time frame
day 0, day 1 and day 3

Secondary outcomes

1

improving intercostal tube duration in days

Time frame
day 2, day 4 and day 6
2

improving total hospital stay in days

Time frame
day 2, day 4 and day 6
3

improving patient satisfaction (questionnaire)

Time frame
day 0, day 2, day 4 and day 6

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: